The New York Biotechnology Association (NYBA) on Tuesday announced it has changed to its name to NewYorkBIO to recognize its growth over more than two decades.
Since its launch 23 years ago, the organization has grown from a network of six local companies and universities to become “the largest bioscience trade group” in state, NewYorkBIO said in a news release.
It now represents more than 250 member organizations in every sector of the life- science industry, from therapeutics and diagnostics to medical devices and biotech crops.
The group launched the new brand as part of its mission to serve the “growing” bioscience community in New York, and the expansion of biotechnology into life-science industry.
Its new identity reflects how the association “has matured from a small, biotech-specific trade group into a broad-based organization encompassing not only biotech, but also big pharma, medical device and diagnostics companies, genomic technologies, genetically-engineered crop developers, industrial-biomedical products, and virtually every other sector of the life science industry,” Nathan Tucker, executive director of NewYorkBIO, said in the news release.
The organization has been “particularly effective” in protecting the industry from “undue and unfair” regulation and promoting the industry’s interests while educating state and federal policymakers about the “impact and importance” of bioscience to New York’s economy, Tinker added.
Representing more than 75,000 life-science workers in the state, Stony Brook, N.Y.–based NewYorkBIO is an advocate for advancing the success of the life-science industry statewide and serves as its main representative to state policy makers, the media and communities, the organization said.
Contact The Business Journal at news@cnybj.com